Krawczyk , Paweł. 2013. “Role of Molecular Examinations in Qualification to First Line Treatment With Erlotinib in NSCLC Patients Based on EUTARCstudy Results”. OncoReview 3 (1(9), 26-33. https://journalsmededu.pl/index.php/OncoReview/article/view/332.